Better Therapeutics, Inc.
BTTX
Rank in Stocks
#34833
Better Therapeutics, Inc., a prescription digital therapeutics company,... Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company’s lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company’s clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis ,and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.
Share Price
$0.0001
Last synced: 2026-11-09
Market Cap
$3.85K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Better Therapeutics, Inc. (BTTX)
Category
Healthcare
Operating Margin for Better Therapeutics, Inc. (BTTX)
Operating Margin as of November 2026 TTM: 0.00%
According to Better Therapeutics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2022 the company had an operating margin of 0.00%.
Operating Margin history for Better Therapeutics, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -79,037.50% | 146.44% |
| 2019 | -32,072.22% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 18.91% | - |
IE
|
|
| 10.95% | - |
CN
|
|
| 25.26% | - |
CH
|
|
| 13.54% | - |
CH
|
|
| 38.62% | - |
CN
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Better Therapeutics, Inc.'s operating margin
What was Better Therapeutics, Inc.'s operating margin in 2022?
In 2022, Better Therapeutics, Inc.'s operating margin was 0.00%, compared with 0.00% in 2021.
How has Better Therapeutics, Inc.'s operating margin changed since 2019?
From 2019 to 2022, Better Therapeutics, Inc.'s operating margin was highest in 2022 (0.00%) and lowest in 2020 (-79,037.50%).
How does Better Therapeutics, Inc.'s operating margin compare with similar companies?
Better Therapeutics, Inc.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Jafron Biomedical Co.,Ltd., with 38.62%.